These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8842505)

  • 41. A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
    Insel J; Mirvis DM; Boland MJ; Cinquegrani MP; Shanes J; Rubin SA; Whalen JJ
    Clin Pharmacol Ther; 1989 Mar; 45(3):312-20. PubMed ID: 2537699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.
    Sütsch G; Kiowski W; Yan XW; Hunziker P; Christen S; Strobel W; Kim JH; Rickenbacher P; Bertel O
    Circulation; 1998 Nov; 98(21):2262-8. PubMed ID: 9826312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group.
    Feneck RO
    J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):554-62. PubMed ID: 1421066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition.
    Kiowski W; Beermann J; Rickenbacher P; Haemmerli R; Thomas M; Burkart F; Meinertz T
    Circulation; 1994 Dec; 90(6):2748-56. PubMed ID: 7994817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic effects of alpha1-adrenoceptor antagonist, doxazosin, in patients with chronic congestive heart failure.
    Kieback AG; Rödiger O; Jaenecke H; Grohmann A; Wernecke KD; Baumann G; Felix SB
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):399-404. PubMed ID: 16160589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Wimmer A; Stanek B; Kubecova L; Vitovec J; Spinar J; Yilmaz N; Kos T; Hartter E; Frey B; Pacher R
    Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study on the effectiveness of toborinone (OPC-18790) in the treatment of heart failure in patients following cardiac surgery.
    Hirata T; Akamatsu T; Horinokuchi N; Uchida O; Kuro M
    Arzneimittelforschung; 1999 Jun; 49(6):499-503. PubMed ID: 10417865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
    Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
    Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure.
    Abraham WT; Lowes BD; White M; Ferguson DA; Scheffel CA; Wolfel EE; Lindenfeld J; Bristow MR
    J Card Fail; 1994 Oct; 1(1):57-62. PubMed ID: 9420633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute clinical benefits of a new inotropic agent AR-L 115 BS after i.v. and oral administration.
    el Allaf D; D'Orio V; Cremers S; Carlier J
    G Ital Cardiol; 1984 Oct; 14(10):830-4. PubMed ID: 6519393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors.
    Gottlieb SS; Kukin ML; Penn J; Fisher ML; Cines M; Medina N; Yushak M; Taylor M; Packer M
    J Am Coll Cardiol; 1993 Oct; 22(4):963-7. PubMed ID: 8409070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hemodynamic effects of oral captopril in patients with critical aortic stenosis].
    Martínez Sánchez C; Henne O; Arceo A; Peña M; González H; Chuquiure E; Lupi E
    Arch Inst Cardiol Mex; 1996; 66(4):322-30. PubMed ID: 8984953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term vasodilator treatment with flosequinan does not lead to hemodynamic tolerance or neurohormonal activation in severe heart failure.
    Bartels GL; Remme WJ; Look MP; Kruijssen DA
    J Card Fail; 1995 Mar; 1(2):117-25. PubMed ID: 9420641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac function and peripheral circulatory adjustments in patients with acute myocardial infarction. Observations during the early stage of AMI.
    Seino Y
    Jpn Heart J; 1983 Jul; 24(4):515-28. PubMed ID: 6645046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial.
    Franciosa JA; Jordan RA; Wilen MM; Leddy CL
    Circulation; 1984 Jul; 70(1):63-8. PubMed ID: 6373050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Acute effect of enoximone and captopril in patients with heart failure].
    Scholz M; Kneissl GD; Dieterich HA; Kaltenbach M; Bussmann WD
    Z Kardiol; 1991; 80 Suppl 4():69-74. PubMed ID: 1833901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and hemodynamic experience with enalapril in congestive heart failure.
    Cody RJ
    Am J Cardiol; 1985 Jan; 55(2):36A-40A. PubMed ID: 2981464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.